You are using an outdated browser. For a faster, safer browsing experience, upgrade for free today.

Life & Medical Care

Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size, Status and Forecast 2020-2026

Gastroesophageal reflux disease (GERD), also known as acid reflux, is a long-term condition where stomach contents come back up into the esophagus resulting in either symptoms or complications.
Patent expiry of blockbuster drugs prescribed for the treatment of acid reflux disorders is majorly attributable for the downfall of this market.
Market Analysis and Insights: Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market
In 2019, the global Gastroesophageal Reflux Disease (GERD) Therapeutics market size was US$ 4733.1 million and it is expected to reach US$ 4950.1 million by the end of 2026, with a CAGR of 0.6% during 2021-2026.
Global Gastroesophageal Reflux Disease (GERD) Therapeutics Scope and Market Size
Gastroesophageal Reflux Disease (GERD) Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Gastroesophageal Reflux Disease (GERD) Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Segment by Type, the Gastroesophageal Reflux Disease (GERD) Therapeutics market is segmented into Antacids, Pro-kinetic agents, H2 Receptor Blockers, Proton Pump Inhibitors (PPIs), etc.
Segment by Application, the Gastroesophageal Reflux Disease (GERD) Therapeutics market is segmented into Heartburn, Acid reflux disorders, etc.
Regional and Country-level Analysis
The Gastroesophageal Reflux Disease (GERD) Therapeutics market is analysed and market size information is provided by regions (countries).
The key regions covered in the Gastroesophageal Reflux Disease (GERD) Therapeutics market report are North America, Europe, China, Japan, Southeast Asia, India and Central & South America, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of revenue for the period 2015-2026.
Competitive Landscape and Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share Analysis
Gastroesophageal Reflux Disease (GERD) Therapeutics market competitive landscape provides details and data information by vendors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by player for the period 2015-2020. Details included are company description, major business, company total revenue and the revenue generated in Gastroesophageal Reflux Disease (GERD) Therapeutics business, the date to enter into the Gastroesophageal Reflux Disease (GERD) Therapeutics market, Gastroesophageal Reflux Disease (GERD) Therapeutics product introduction, recent developments, etc.
The major vendors include AstraZeneca, Eisai, GSK, Takeda, Johnson & Johnson, etc.

This report focuses on the global Gastroesophageal Reflux Disease (GERD) Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Gastroesophageal Reflux Disease (GERD) Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study
AstraZeneca
Eisai
GSK
Takeda
Johnson & Johnson
...

Market segment by Type, the product can be split into
Antacids
Pro-kinetic agents
H2 Receptor Blockers
Proton Pump Inhibitors (PPIs)
Market segment by Application, split into
Heartburn
Acid reflux disorders

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Gastroesophageal Reflux Disease (GERD) Therapeutics status, future forecast, growth opportunity, key market and key players.
To present the Gastroesophageal Reflux Disease (GERD) Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Gastroesophageal Reflux Disease (GERD) Therapeutics are as follows:
History Year: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue
1.4 Market Analysis by Type
1.4.1 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Antacids
1.4.3 Pro-kinetic agents
1.4.4 H2 Receptor Blockers
1.4.5 Proton Pump Inhibitors (PPIs)
1.5 Market by Application
1.5.1 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Application: 2020 VS 2026
1.5.2 Heartburn
1.5.3 Acid reflux disorders
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends by Regions
2.1 Gastroesophageal Reflux Disease (GERD) Therapeutics Market Perspective (2015-2026)
2.2 Gastroesophageal Reflux Disease (GERD) Therapeutics Growth Trends by Regions
2.2.1 Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Gastroesophageal Reflux Disease (GERD) Therapeutics Historic Market Share by Regions (2015-2020)
2.2.3 Gastroesophageal Reflux Disease (GERD) Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Gastroesophageal Reflux Disease (GERD) Therapeutics Market Growth Strategy
2.3.6 Primary Interviews with Key Gastroesophageal Reflux Disease (GERD) Therapeutics Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Gastroesophageal Reflux Disease (GERD) Therapeutics Players by Market Size
3.1.1 Global Top Gastroesophageal Reflux Disease (GERD) Therapeutics Players by Revenue (2015-2020)
3.1.2 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue Market Share by Players (2015-2020)
3.1.3 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Concentration Ratio
3.2.1 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue in 2019
3.3 Gastroesophageal Reflux Disease (GERD) Therapeutics Key Players Head office and Area Served
3.4 Key Players Gastroesophageal Reflux Disease (GERD) Therapeutics Product Solution and Service
3.5 Date of Enter into Gastroesophageal Reflux Disease (GERD) Therapeutics Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)
4.1 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Forecasted Market Size by Type (2021-2026)

5 Gastroesophageal Reflux Disease (GERD) Therapeutics Breakdown Data by Application (2015-2026)
5.1 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Application (2015-2020)
5.2 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size (2015-2020)
6.2 Gastroesophageal Reflux Disease (GERD) Therapeutics Key Players in North America (2019-2020)
6.3 North America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Type (2015-2020)
6.4 North America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Application (2015-2020)

7 Europe
7.1 Europe Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size (2015-2020)
7.2 Gastroesophageal Reflux Disease (GERD) Therapeutics Key Players in Europe (2019-2020)
7.3 Europe Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Type (2015-2020)
7.4 Europe Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Application (2015-2020)

8 China
8.1 China Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size (2015-2020)
8.2 Gastroesophageal Reflux Disease (GERD) Therapeutics Key Players in China (2019-2020)
8.3 China Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Type (2015-2020)
8.4 China Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Application (2015-2020)

9 Japan
9.1 Japan Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size (2015-2020)
9.2 Gastroesophageal Reflux Disease (GERD) Therapeutics Key Players in Japan (2019-2020)
9.3 Japan Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Type (2015-2020)
9.4 Japan Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size (2015-2020)
10.2 Gastroesophageal Reflux Disease (GERD) Therapeutics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Type (2015-2020)
10.4 Southeast Asia Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Application (2015-2020)

11 India
11.1 India Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size (2015-2020)
11.2 Gastroesophageal Reflux Disease (GERD) Therapeutics Key Players in India (2019-2020)
11.3 India Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Type (2015-2020)
11.4 India Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size (2015-2020)
12.2 Gastroesophageal Reflux Disease (GERD) Therapeutics Key Players in Central & South America (2019-2020)
12.3 Central & South America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Type (2015-2020)
12.4 Central & South America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 AstraZeneca
13.1.1 AstraZeneca Company Details
13.1.2 AstraZeneca Business Overview and Its Total Revenue
13.1.3 AstraZeneca Gastroesophageal Reflux Disease (GERD) Therapeutics Introduction
13.1.4 AstraZeneca Revenue in Gastroesophageal Reflux Disease (GERD) Therapeutics Business (2015-2020))
13.1.5 AstraZeneca Recent Development
13.2 Eisai
13.2.1 Eisai Company Details
13.2.2 Eisai Business Overview and Its Total Revenue
13.2.3 Eisai Gastroesophageal Reflux Disease (GERD) Therapeutics Introduction
13.2.4 Eisai Revenue in Gastroesophageal Reflux Disease (GERD) Therapeutics Business (2015-2020)
13.2.5 Eisai Recent Development
13.3 GSK
13.3.1 GSK Company Details
13.3.2 GSK Business Overview and Its Total Revenue
13.3.3 GSK Gastroesophageal Reflux Disease (GERD) Therapeutics Introduction
13.3.4 GSK Revenue in Gastroesophageal Reflux Disease (GERD) Therapeutics Business (2015-2020)
13.3.5 GSK Recent Development
13.4 Takeda
13.4.1 Takeda Company Details
13.4.2 Takeda Business Overview and Its Total Revenue
13.4.3 Takeda Gastroesophageal Reflux Disease (GERD) Therapeutics Introduction
13.4.4 Takeda Revenue in Gastroesophageal Reflux Disease (GERD) Therapeutics Business (2015-2020)
13.4.5 Takeda Recent Development
13.5 Johnson & Johnson
13.5.1 Johnson & Johnson Company Details
13.5.2 Johnson & Johnson Business Overview and Its Total Revenue
13.5.3 Johnson & Johnson Gastroesophageal Reflux Disease (GERD) Therapeutics Introduction
13.5.4 Johnson & Johnson Revenue in Gastroesophageal Reflux Disease (GERD) Therapeutics Business (2015-2020)
13.5.5 Johnson & Johnson Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
  • FORMAT: PDF
  • PUBLISHED DATE: Mar, 2020
  • NO OF PAGES: 125